912
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Placenta accreta spectrum: ultrasound diagnosis and clinical correlation

, &
Article: 2287238 | Received 02 Aug 2023, Accepted 17 Nov 2023, Published online: 30 Nov 2023

References

  • Jauniaux E, Bunce C, Grønbeck L, et al. Prevalence and main outcomes of placenta accreta spectrum: a systematic review and meta-analysis. Am J Obstet Gynecol. 2019;221:1–12. doi: 10.1016/j.ajog.2019.01.233.
  • Collins S, Chantraine F, Morgan T, et al. Abnormally adherent and invasive placenta: a spectrum disorder in need of a name. Ultrasound Obstet Gynecol. 2018;51:165–166. doi: 10.1002/uog.18982.
  • Hecht J, Baergen R, Ernst L, et al. Classification and reporting guidelines for the pathology diagnosis of placenta accreta spectrum (PAS) disorders: recommendations from an expert panel. Mod Pathol. 2020;33:2382–2396. doi: 10.1038/s41379-020-0569-1.
  • Luke R, Sharpe J, Greene R. Placenta accreta: the adherent or invasive placenta. Am J Obstet Gynecol. 1966;95:660–668. doi: 10.1016/s0002-9378(16)34741-x.
  • Jauniaux E, Chantraine F, Silver R, et al. FIGO placenta accreta diagnosis and management expert consensus panel FIGO consensus guidelines on placenta accreta spectrum disorders: epidemiology. Int J Gynaecol Obstet. 2018;140:265–273. doi: 10.1002/ijgo.12407.
  • Zahn C, Ramsey P, Toy E, et al. Placenta accrete spectrum disorder clinical and Designation Guideline ACOG webinar December 2, 2022.
  • Sentilhes L, Merlot B, Madar H, et al. Postpartum haemorrhage: prevention and treatment. Expert Rev Hematol. 2016;9:1043–1061. doi: 10.1080/17474086.2016.1245135.
  • Kamara M, Henderson J, Doherty D, et al. The risk of placenta accreta following primary electve caesarean delivery: a case-control study. BJOG. 2013;120 :879–886. doi: 10.1111/1471-0528.12148.
  • Wu S, Kocherginsky M, Hibbard J. Abnormal placentaton: twenty year analysis. Am J Obstet Gynecol. 2005;192:1458–1461. doi: 10.1016/j.ajog.2004.12.074.
  • Higgins M, Monteith C, Foley M, et al. Real increasing incidence of hysterectomy for placenta accreta following previous caesarean section. Eur J Obstet Gynecol Reprod Biol. 2013;171:54–56. doi: 10.1016/j.ejogrb.2013.08.030.
  • Cheng K, Lee M. Rising incidence of morbidly adherent placenta and its association with previous caesarean secton: a 15-year analysis in a tertiary hospital in Hong Kong. Hong Kong Med J. 2015;21:511–517. doi: 10.12809/hkmj154599.
  • Klar M, Michels K. Cesarean secton and placental disorders in subsequent pregnancies—a meta-analysis. J Perinat Med. 2014;42:571–583. doi: 10.1515/jpm-2013-0199.
  • Colmorn L, Petersen K, Jakobsson M, et al. The nordic obstetric surveillance study: a study of complete uterine rupture, abnormally invasive placenta, peripartum hysterectomy, and severe blood loss at delivery. Acta Obstet Gynecol Scand. 2015;94:734–744. doi: 10.1111/aogs.12639.
  • Silver R, Landon M, Rouse D, et al. Maternal morbidity associated with multiple repeat cesarean delivery. Obstet Gynecol. 2006;107:1226–1232. doi: 10.1097/01.AOG.0000219750.79480.84.
  • Jauniaux E, Burton G. Pathophysiology of placenta accreta spectrum disorders: a review of current findings. Clin Obstet Gynecol. 2018;61:743–754. doi: 10.1097/GRF.0000000000000392.
  • Piñas Carrillo A, Chandraharan E. Placenta accreta ­spectrum; risk factors, diagnosis and management to the triple P procedure. Womens Health (Lond). 2019;15:1745506519878081. doi: 10.1177/1745506519878081.
  • Eshkoli T, Weintraub AY, Sergienko R, et al. Placenta accreta: risk factors, perinatal outcomes, and consequences for subsequent births. Am J Obstet Gynecol. 2013;208:219.e1-7–219.e7. doi: 10.1016/j.ajog.2012.12.037.
  • Fitzpatrick K, Sellers S, Spark P, et al. Incidence and risk factors for placenta accreta/increta/percreta in the UK: a national case-control study. PLoS One. 2012;7:e52893. doi: 10.1371/journal.pone.0052893.
  • Kaser D, Melamed A, Bormann C, et al. Cryopreserved embryo transfer is an independent risk factor for placenta accreta. Fertil Steril. 2015;103:1176–1184.e2. doi: 10.1016/j.fertnstert.2015.01.021.
  • Marshall N, Fu R, Guise J. Impact of multiple cesarean deliveries on maternal morbidity: a systematic review. Am J Obstet Gynecol. 2011;205:262.e1-8–262.e8. doi: 10.1016/j.ajog.2011.06.035.
  • Jauniaux E, Collins S, Burton G. Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging. Am J Obstet Gynecol. 2018;218:75–87. doi: 10.1016/j.ajog.2017.05.067.
  • Jauniaux E, Collins S, Jurkovic D, et al. Accreta placentation: a systematic review of prenatal ultrasound imaging and grading of villous invasiveness. Am J Obstet Gynecol. 2016;215:712–721. doi: 10.1016/j.ajog.2016.07.044.
  • Benirschke K, Burton G, Baergen R. Pathology of the human placenta, 6th edition. Berlin: Springer-Verlag, 2012.
  • Morlando M, Collins S. Placenta accreta spectrum disorders: challenges, risks, and management strategies. Int J Womens Health. 2020;12:1033–1045. doi: 10.2147/IJWH.S224191.
  • Jauniaux E, Jurkovic D, Hussein AM, et al. New insights into the etiopathology of placenta accreta spectrum. Am J Obstet Gynecol. 2022;227:384–391. doi: 10.1016/j.ajog.2022.02.038.
  • Findeklee S, Costa S. Placenta accreta and total placenta previa in the 19th week of pregnancy. Geburtshilfe Frauenheilkd. 2015;75:839–843. doi: 10.1055/s-0035-1557763.
  • Chou M, Ho E. Prenatal diagnosis of placenta previa accreta with power amplitude ultrasonic angiography. Am J Obstet Gynecol. 1997;177:1523–1525. doi: 10.1016/s0002-9378(97)70102-9.
  • Hamada S, Hasegawa J, Nakamura M, et al. Ultrasonographic findings of placenta lacunae and a lack of a clear zone in cases with placenta previa and normal placenta. Prenat Diagn. 2011;31:1062–1065. doi: 10.1002/pd.2833.
  • Wong HS, Cheung YK, Zuccollo J, et al. Evaluation of sonographic diagnostic criteria for placenta accreta. J Clin Ultrasound. 2008;36:551–559. doi: 10.1002/jcu.20524.
  • Rac M, Dashe J, Wells C, et al. Ultrasound predictors of placental invasion: the placenta accreta index. Am J Obstet Gynecol. 2015;212:343.e1-7–343.e7. doi: 10.1016/j.ajog.2014.10.022.
  • Comstock C, Love J, Bronsteen R, et al. Sonographic detection of placenta accreta in the second and third trimesters of pregnancy. Am J Obstet Gynecol. 2004;190:1135–1140. doi: 10.1016/j.ajog.2003.11.024.
  • Nunes C, Carvalho R, Araújo C, et al. Diagnosis of placenta accreta by ultrasonography: a ‘gold standard’. Acta Obstet Ginecol Port. 2014;8:136–140.
  • Japaraj R, Mimin T, Mukudan K. Antenatal diagnosis of placenta previa accreta in patients with previous cesarean scar. J Obstet Gynaecol Res. 2007;33:431–437. doi: 10.1111/j.1447-0756.2007.00549.x.
  • Jauniaux E, Campbell S. Ultrasonographic assessment of placental abnormalities. Am J Obstet Gynecol. 1990;163(5 Pt 1):1650–1658. doi: 10.1016/0002-9378(90)90645-n.
  • Cramer S, Heller D. Placenta accreta and placenta increta: an approach to pathogenesis based on the trophoblastic differentiation pathway. Pediatr Dev Pathol. 2016;19:320–333. doi: 10.2350/15-05-1641-OA.1.
  • Jauniaux E. Partial moles: from postnatal to prenatal diagnosis. Placenta. 1999;20:379–388. doi: 10.1053/plac.1999.0390.
  • Schiffer V, van Haren A, De Cubber L, et al. Ultrasound evaluation of the placenta in healthy and placental syndrome pregnancies: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2021;262:45–56. doi: 10.1016/j.ejogrb.2021.04.042.
  • Shih J, Jaraquemada J, Su Y, et al. Role of three-dimensional power doppler in the antenatal diagnosis of placenta accreta: comparison with gray-scale and color doppler techniques. Ultrasound Obstet Gynecol. 2009;33:193–203. doi: 10.1002/uog.6284.
  • Matsuo K, Conturie C, Lee R. Snowman sign: a possible predictor of catastrophic abnormal placentation. Eur J Obstet Gynecol Reprod Biol. 2014;181:341–342. doi: 10.1016/j.ejogrb.2014.07.035.
  • Chantraine F, Blacher S, Berndt S, et al. Abnormal vascular architecture at the placental-maternal interface in placenta increta. Am J Obstet Gynecol. 2012;207:188.e1-9–188.e9. doi: 10.1016/j.ajog.2012.06.083.
  • Schaaps J, Tsatsaris V, Goffin F, et al. Shunting the intervillous space: new concepts in human uteroplacental vascularization. Am J Obstet Gynecol. 2005;192(1):323–332. doi: 10.1016/j.ajog.2004.06.066.
  • Krapp M, Baschat A, Hankeln M, et al. Gray scale and color doppler sonography in the third stage of labor for early detection of failed placental separation. Ultrasound Obstet Gynecol. 2000;15:138–142. doi: 10.1046/j.1469-0705.2000.00063.x.
  • Jauniaux E, D'Antonio F, Bhide A, et al. Modified Delphi study of ultrasound signs associated with placenta accreta spectrum. Ultrasound Obstet Gynecol. 2023;61:518–525. doi: 10.1002/uog.26155.
  • Collins S, Stevenson G, Al-Khan A, et al. Three-Dimensional power doppler ultrasonography for diagnosing abnormally invasive placenta and quantifying the risk. Obstet Gynecol. 2015;126:645–653. doi: 10.1097/AOG.0000000000000962.
  • Rossetti D, Vitale S, Bogani G, et al. Usefulness of vessel-sealing devices for peripartum hysterectomy: a retrospective cohort study. Updates Surg. 2015;67:301–304. doi: 10.1007/s13304-015-0289-0.
  • Silver RM, Fox KA, Barton JR, et al. Center of excellence for placenta accrete. Am J Obstet Gynecol. 2015;212:561–568. doi: 10.1016/j.ajog.2014.11.018.
  • Warshak C, Ramos G, Eskander R, et al. Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta. Obstet Gynecol. 2010;115:65–69. doi: 10.1097/AOG.0b013e3181c4f12a.
  • D'Antonio F, Palacios-Jaraquemada J, Lim P, et al. Counseling in fetal medicine: evidence-based answers to clinical questions on morbidly adherent placenta. Ultrasound Obstet Gynecol. 2016;47:290–301. doi: 10.1002/uog.14950.